241
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Anatomical Distribution Patterns of Peripheral Arterial Disease According to Patient Characteristics: A Unicentral Cohort Study

, ORCID Icon, , , , ORCID Icon, & show all
Pages 447-457 | Received 13 Apr 2023, Accepted 20 Jun 2023, Published online: 17 Jul 2023

References

  • Kiss LZ, Bagyura Z, Vadas R, et al. Signs of subclinical atherosclerosis in asymptomatic patients at increased risk of type 2 diabetes mellitus. J Diabetes Complications. 2017;31(8):1293–1298. doi:10.1016/j.jdiacomp.2017.05.007
  • Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340. doi:10.1016/S0140-6736(13)61249-0
  • Huo J, Wu Z, Jiang H, Zhang H. Multislice computed tomography angiography imaging diagnosis of lower extremity arteriosclerosis in patients with hypertension and its correlation with the level of high-sensitivity C-reactive protein. Comput Math Methods Med. 2022;2022:1768208. doi:10.1155/2022/1768208
  • Tang T, Kum S, Ho P, Tan Y. Peripheral vascular disease and endovascular therapy in Singapore. In: Dardik A, editor. Vascular Surgery. Cham: Springer; 2017:81–90.
  • Soon SXY, Patel A, Chong TT, et al. Distribution of peripheral arterial disease in patients undergoing endovascular revascularization for chronic limb threatening ischaemia: insights from the vascular quality initiative in Singapore. Vasc Specialist Int. 2021;37:13. doi:10.5758/vsi.210016
  • Al-Sheikh SO, Aljabri BA, Al-Ansary LA, Al Khayal LA, Al Salman MM, Al Omran MA. Prevalence of and risk factors for peripheral arterial disease in Saudi Arabia. A pilot cross-sectional study. Saudi Med J. 2007;28(3):412–414.
  • Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag. 2007;3(2):229–234. doi:10.2147/vhrm.2007.3.2.229
  • Ness J, Aronow WS, Newkirk E, McDanel D. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. J Gerontol a Biol Sci Med Sci. 2005;60(2):255–257. doi:10.1093/gerona/60.2.255
  • Aronow WS. State of the art paper Peripheral arterial disease of the lower extremities. Arch Med Sci. 2012;8(2):375–388. doi:10.5114/aoms.2012.28568
  • World Health Organization. WHO report on the global tobacco epidemic, 2021: addressing new and emerging products; 2021. Available from: https://www.who.int/teams/health-promotion/tobacco-control/global-tobacco-report-2021. Accessed June 5, 2023.
  • Ohtake T, Mitomo A, Yamano M, et al. Impact of arterial calcification of the lower limbs on long-term clinical outcomes in patients on hemodialysis. J Clin Med. 2023;12(4):1299. doi:10.3390/jcm12041299
  • Ogunwole SM, Chen X, Mitta S, et al. Interconception care for primary care providers: consensus recommendations on preconception and postpartum management of reproductive-age patients with medical comorbidities. Mayo Clin Proc Innov Qual Outcomes. 2021;5(5):872–890. doi:10.1016/j.mayocpiqo.2021.08.004
  • Takahara M, Soga Y, Fujihara M, Iida O, Kawasaki D. Association of smoking, diabetes, and dialysis with the presence of popliteal lesions in femoropopliteal artery disease. J Atheroscler Thromb. 2022;64007. doi:10.5551/jat.64007
  • Lowry D, Saeed M, Narendran P, Tiwari A. A review of distribution of atherosclerosis in the lower limb arteries of patients with diabetes mellitus and peripheral vascular disease. Vasc Endovascular Surg. 2018;52(7):535–542. doi:10.1177/1538574418791622
  • Mufti AAI, Subki AH, Abushanab RH, et al. Peripheral artery disease risk factors in Jeddah, Saudi Arabia: a retrospective study. Int J Gen Med. 2019;12:49–54. doi:10.2147/IJGM.S176451
  • González-Becerra K, Ramos-López O, Barrón-Cabrera E, et al. Fatty acids, epigenetic mechanisms and chronic diseases: a systematic review. Lipids Health Dis. 2019;18(1):178. doi:10.1186/s12944-019-1120-6
  • Markin AM, Sobenin IA, Grechko AV, Zhang D, Orekhov AN. Cellular mechanisms of human atherogenesis: focus on chronification of inflammation and mitochondrial mutations. Front Pharmacol. 2020;11:642. doi:10.3389/fphar.2020.00642
  • Yang Z, Han B, Zhang H, Ji G, Zhang L, Singh BK. Association of lower extremity vascular disease, coronary artery, and carotid artery atherosclerosis in patients with type 2 diabetes mellitus. Comput Math Methods Med. 2021;2021:6268856. doi:10.1155/2021/6268856
  • Motsumi MJ, Naidoo NG. Pattern and distribution of peripheral arterial disease in diabetic patients with critical limb ischemia (Rutherford clinical category 4–6). S Afr J Surg. 2017;55(3):48–54.
  • Chung J, Modrall JG, Knowles M, et al. Arteriographic patterns of atherosclerosis and the association between diabetes mellitus and ethnicity in chronic critical limb ischemia. Ann Vasc Surg. 2017;40:198–205. doi:10.1016/j.avsg.2016.11.003
  • Diehm N, Shang A, Silvestro A, et al. Association of cardiovascular risk factors with pattern of lower limb atherosclerosis in 2659 patients undergoing angioplasty. Eur J Vasc Endovas Surg. 2006;31(1):59–63. doi:10.1016/j.ejvs.2005.09.006
  • Arya S, Binney ZO, Khakharia A, et al. High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg. 2018;67(1):217–228.e1. doi:10.1016/j.jvs.2017.06.101
  • Shatnawi NJ, Al-Zoubi NA, Hawamdeh HM, et al. The relation of anatomical distribution of symptomatic peripheral arterial disease (PAD) with HbA1c level in patients with type 2 diabetes mellitus. Ther Adv Endocrinol Metab. 2021;12:20420188211000504. doi:10.1177/20420188211000504
  • Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6(7):961–969. doi:10.4239/wjd.v6.i7.961
  • Chou TH, Rimmerman ET, Patel S, et al. Vessel-by-vessel analysis of lower extremity 18F-NaF PET/CT imaging quantifies diabetes-and chronic kidney disease-induced active microcalcification in patients with peripheral arterial disease. EJNMMI Res. 2023;13(1):1. doi:10.1186/s13550-023-00951-0
  • Kourtidou C, Rafailidis V, Varouktsi G, et al. Evaluation of subclinical vascular disease in diabetic kidney disease: a tool for personalization of management of a high-risk population. J Pers Med. 2022;12(7):1139. doi:10.3390/jpm12071139
  • Keller K, Schmitt VH, Vosseler M, et al. Diabetes mellitus and its impact on patient-profile and in-hospital outcomes in peripheral artery disease. J Clin Med. 2021;10(21):5033. doi:10.3390/jcm10215033
  • Haltmayer M, Mueller T, Horvath W, Luft C, Poelz W, Haidinger D. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol. 2001;20(3):200–207.
  • Rencüzoğulları I, Çınar T, Karabağ Y. Endothelin-1 and C reactive protein as potential biomarkers for restenosis in patients with arteriosclerosis obliterans. J Invest Surg. 2021;34(7):771–772. doi:10.1080/08941939.2019.1693668